BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

521 related articles for article (PubMed ID: 35381574)

  • 1. Recent advances in lipid nanoparticles for delivery of nucleic acid, mRNA, and gene editing-based therapeutics.
    Mukai H; Ogawa K; Kato N; Kawakami S
    Drug Metab Pharmacokinet; 2022 Jun; 44():100450. PubMed ID: 35381574
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Developing Biodegradable Lipid Nanoparticles for Intracellular mRNA Delivery and Genome Editing.
    Qiu M; Li Y; Bloomer H; Xu Q
    Acc Chem Res; 2021 Nov; 54(21):4001-4011. PubMed ID: 34668716
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemistry of Lipid Nanoparticles for RNA Delivery.
    Eygeris Y; Gupta M; Kim J; Sahay G
    Acc Chem Res; 2022 Jan; 55(1):2-12. PubMed ID: 34850635
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ionizable Lipid Nanoparticles for Therapeutic Base Editing of Congenital Brain Disease.
    Palanki R; Bose SK; Dave A; White BM; Berkowitz C; Luks V; Yaqoob F; Han E; Swingle KL; Menon P; Hodgson E; Biswas A; Billingsley MM; Li L; Yiping F; Carpenter M; Trokhan A; Yeo J; Johana N; Wan TY; Alameh MG; Bennett FC; Storm PB; Jain R; Chan J; Weissman D; Mitchell MJ; Peranteau WH
    ACS Nano; 2023 Jul; 17(14):13594-13610. PubMed ID: 37458484
    [TBL] [Abstract][Full Text] [Related]  

  • 5. mRNA delivery technologies: Toward clinical translation.
    Gómez-Aguado I; Rodríguez-Castejón J; Beraza-Millor M; Rodríguez-Gascón A; Del Pozo-Rodríguez A; Solinís MÁ
    Int Rev Cell Mol Biol; 2022; 372():207-293. PubMed ID: 36064265
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intracellular Delivery of mRNA for Cell-Selective CRISPR/Cas9 Genome Editing using Lipid Nanoparticles.
    Ma T; Chen X; Wang M
    Chembiochem; 2023 May; 24(9):e202200801. PubMed ID: 36780174
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lipid nanoparticles for delivery of RNA therapeutics: Current status and the role of
    Jung HN; Lee SY; Lee S; Youn H; Im HJ
    Theranostics; 2022; 12(17):7509-7531. PubMed ID: 36438494
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A tale of nucleic acid-ionizable lipid nanoparticles: Design and manufacturing technology and advancement.
    De A; Ko YT
    Expert Opin Drug Deliv; 2023 Jan; 20(1):75-91. PubMed ID: 36445261
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Flash nanoprecipitation assisted self-assembly of ionizable lipid nanoparticles for nucleic acid delivery.
    Misra B; Hughes KA; Pentz WH; Samart P; Geldenhuys WJ; Bobbala S
    Nanoscale; 2024 Apr; 16(14):6939-6948. PubMed ID: 38511623
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recent Advances in the Lipid Nanoparticle-Mediated Delivery of mRNA Vaccines.
    Swetha K; Kotla NG; Tunki L; Jayaraj A; Bhargava SK; Hu H; Bonam SR; Kurapati R
    Vaccines (Basel); 2023 Mar; 11(3):. PubMed ID: 36992242
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ionizable lipid nanoparticles encapsulating barcoded mRNA for accelerated in vivo delivery screening.
    Guimaraes PPG; Zhang R; Spektor R; Tan M; Chung A; Billingsley MM; El-Mayta R; Riley RS; Wang L; Wilson JM; Mitchell MJ
    J Control Release; 2019 Dec; 316():404-417. PubMed ID: 31678653
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enzyme-Catalyzed One-Step Synthesis of Ionizable Cationic Lipids for Lipid Nanoparticle-Based mRNA COVID-19 Vaccines.
    Li Z; Zhang XQ; Ho W; Li F; Gao M; Bai X; Xu X
    ACS Nano; 2022 Nov; 16(11):18936-18950. PubMed ID: 36269150
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recent advances in delivering RNA-based therapeutics to mitochondria.
    Yamada Y; Ishizuka S; Arai M; Maruyama M; Harashima H
    Expert Opin Biol Ther; 2022 Sep; 22(9):1209-1219. PubMed ID: 35543589
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hydroxycholesterol substitution in ionizable lipid nanoparticles for mRNA delivery to T cells.
    Patel SK; Billingsley MM; Frazee C; Han X; Swingle KL; Qin J; Alameh MG; Wang K; Weissman D; Mitchell MJ
    J Control Release; 2022 Jul; 347():521-532. PubMed ID: 35569584
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lipid nanoparticles (LNPs) for in vivo RNA delivery and their breakthrough technology for future applications.
    Jeong M; Lee Y; Park J; Jung H; Lee H
    Adv Drug Deliv Rev; 2023 Sep; 200():114990. PubMed ID: 37423563
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lipid Nanoparticle-mRNA Formulations for Therapeutic Applications.
    Wang C; Zhang Y; Dong Y
    Acc Chem Res; 2021 Dec; 54(23):4283-4293. PubMed ID: 34793124
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ionizable lipid nanoparticles for in utero mRNA delivery.
    Riley RS; Kashyap MV; Billingsley MM; White B; Alameh MG; Bose SK; Zoltick PW; Li H; Zhang R; Cheng AY; Weissman D; Peranteau WH; Mitchell MJ
    Sci Adv; 2021 Jan; 7(3):. PubMed ID: 33523869
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lipid Nanoparticles─From Liposomes to mRNA Vaccine Delivery, a Landscape of Research Diversity and Advancement.
    Tenchov R; Bird R; Curtze AE; Zhou Q
    ACS Nano; 2021 Nov; 15(11):16982-17015. PubMed ID: 34181394
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ionizable Lipids from Click Reactions for Lipid Nanoparticle Assembling and mRNA Delivery.
    Xu F; Si X; Wang Y; Sun C; Liu M; Zhang Y; Xu X; Tian T
    J Phys Chem B; 2024 Apr; 128(15):3643-3651. PubMed ID: 38588455
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Advances in lipid nanoparticle mRNA therapeutics beyond COVID-19 vaccines.
    Wu Y; Yu S; de Lázaro I
    Nanoscale; 2024 Apr; 16(14):6820-6836. PubMed ID: 38502114
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.